Open Access Review

Drug-induced uveitis

Nikolas JS London1, Sunir J Garg2*, Ramana S Moorthy34 and Emmett T Cunningham56

Author Affiliations

1 Retina Consultants San Diego, 9850 Genesee Avenue, Suite 700, La Jolla, CA, 92037, USA

2 MidAtlantic Retina, The Retina Service of Wills Eye Institute, Thomas Jefferson University, 840 Walnut Street, Suite 1020, Philadelphia, PA, 19107, USA

3 Associated Vitreoretinal and Uveitis Consultants, St. Vincent Hospital and Health Services, Indianapolis, IN, 46260, USA

4 Associate Clinical Professor of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA

5 Department of Ophthalmology, California Pacific Medical Center, San Francisco, CA, 94115, USA

6 Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, 94305-5101, USA

For all author emails, please log on.

Journal of Ophthalmic Inflammation and Infection 2013, 3:43  doi:10.1186/1869-5760-3-43

Published: 25 March 2013

Abstract

A number of medications have been associated with uveitis. This review highlights both well-established and recently reported systemic, topical, intraocular, and vaccine-associated causes of drug-induced uveitis, and assigns a quantitative score to each medication based upon criteria originally described by Naranjo and associates.